At a glance
ClinicalIndex Comparison RecordN/ACompleted· 87 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical and Translational Science Institute Prospective Longitudinal Assessment of Coinfected Subjects With HIV/Hepatitis C for Endothelial Function Study
In Brief
An observational study for HIV and Hepatitis C. Completed, enrolled 87 participants across 1 site.
Detailed Summary
The CTSI-PLACE Study is a study for men and women with HIV/hepatitis C co-infection or HIV only. The study looks at the impact of having hepatitis C virus in addition to HIV on risk for cardiovascular disease. Participants will undergo non-invasive assessment of cardiovascular disease risk through measurements of endothelial function and blood biomarkers at baseline and 1 year (or 4 weeks and 24 weeks after end of HCV treatment for those that undergo HCV treatment during study follow-up).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHIV, Hepatitis C
CountriesUnited States
CollaboratorsMerck Sharp & Dohme LLC
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartOct 2013
First PostedNov 2015
Primary CompletionJan 2019
Study CompletionJan 2020
TodayJul 2026
First PostedNov 5, 2015
Enrollment StartOct 1, 2013
Primary CompletionJan 1, 2019
Study CompletionJan 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 10.7 years ago